Clinical Trial Update: Epistaxis in Patients Receiving Oral Anticoagulants and Antiplatelet: Prevalence Risk Factors at a Tertiary Care Hospital in Nepal

View source ↗

Summary

A completed study from Nepal assessed the prevalence of epistaxis and identified risk factors in patients receiving oral anticoagulants and antiplatelet therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epistaxis

Drugs mentioned

• Oral anticoagulants and antiplatelet therapy (various agents)

Snippet

Sponsor: Institute of medicine, Maharagjung medical campus | Conditions: Epistaxis | Status: COMPLETED